Where does Daniel Yadegar work?

Daniel Yadegar is Co-Founder and Chief Medical Officer at Newpath Partners and Founder at Rinascera Therapeutics and Founder at DermBiont.

What does Daniel Yadegar invest in?

Daniel Yadegar invests in Biotech, Healthtech, Medical Devices.

What check size does Daniel Yadegar write?

Daniel Yadegar typically writes checks of $50K – $10M.

What companies did Daniel Yadegar found?

Daniel Yadegar founded DermBiont, Rinascera Therapeutics.

Daniel Yadegar

InvestorFounder

Co-Founder and Chief Medical Officer at Newpath Partners · Board director at Rinascera Therapeutics · Board director at DermBiont

Writes $50K – $10M checks

FoundedDermBiont Rinascera Therapeutics

About

Daniel Yadegar is a triple board‑certified cardiologist who embeds clinical leadership into fund management as co‑founder and CMO, while leading multiple healthcare platforms, serving on public boards, and practicing clinically.

Invests in

BiotechHealthtechMedical Devices

Board director at Rinascera Therapeutics

Intro paths

→

In turn, Daniel can intro founders to Rinascera Therapeutics's investors below.

Rinascera Therapeutics's investors · 1

Newpath PartnersBoston · $50K – $10M checks · since 2025

Co-founders at Rinascera Therapeutics

Nichola EliovitsExecutive Officer, Director

Max DawsonExecutive Officer

Karl BeutnerExecutive Officer, Director

Board director at DermBiont

Intro paths

→

In turn, Daniel can intro founders to DermBiont's investors below.

DermBiont's investors · 7

Civilization Ventures Management, LlcTiburon · $1M – $10M checks Joyance PartnersBerlin Newpath PartnersBoston · $50K – $10M checks · since 2023 Olive Tree CapitalBoston Start Capital Toba CapitalIrvine · $1M – $10M checks Valia VenturesLondon · $50K – $50M checks

Co-founders at DermBiont

Robert BruckerExecutive Officer

Karl R. BeutnerExecutive Officer, Director

Nichola EliovitsExecutive Officer, Director

Max DawsonExecutive Officer

Deals · 2

Rinascera TherapeuticsBoard seat

via Newpath Partners · filed Oct 2025 · $2.5M raise

DermBiontBoard seat

via Newpath Partners · filed Nov 2024 · $45.3M raise

Attribution from SEC filings, press coverage, and firm rosters.

Colleagues at Newpath Partners

Thomas Cahill

Managing Partner at Newpath Partners

Tom Thomas

Principal at Newpath Partners

Frequently asked questions

Where does Daniel Yadegar work?: Daniel Yadegar is Co-Founder and Chief Medical Officer at Newpath Partners and Founder at Rinascera Therapeutics and Founder at DermBiont.
What does Daniel Yadegar invest in?: Daniel Yadegar invests in Biotech, Healthtech, Medical Devices.
What check size does Daniel Yadegar write?: Daniel Yadegar typically writes checks of $50K – $10M.
What companies did Daniel Yadegar found?: Daniel Yadegar founded DermBiont, Rinascera Therapeutics.